author-photo

Michael Unterhalt

Ludwig Maximilian University of Munich

181

Papers

9388

Citations

Citation Trend

Filter By

Papers (130) Sort By

Journal Conference Others

The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma: A Long Term Pooled Trials Analysis

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (1)
An EZH2 Gene Expression Signature Is Predictive of Differential Efficacy of Chemotherapy Irrespective of EZH2 Mutation Status in Patients with Follicular Lymphoma Treated within the Gallium Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (3)
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network

2019 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (10)
SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Triangle: Autologous Transplantation after a Rituximab/Ibrutinib/ara-c Containing Induction in Generalized Mantle Cell Lymphoma - a Randomized European MCL Network Trial

2019 Blood
Show All
- Source
- Cite
- Save
Citations (3)
AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION-FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Minimal Residual Disease Response at End of Induction and during Maintenance Correlates with Updated Outcome in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-Based Immunochemotherapy in Previously Untreated Follicular Lymphoma Patients

2018 Blood
Show All
- Source
- Cite
- Save
Citations (13)